title: HCV genotype 2 and 3 infections: what is the optimal duration for peginterferon alpha-2b and ribavirin therapy?
authors.affiliation: Duke University Medical Center, Duke Clinical Research Institute, Durham, NC 27710, USA. muir0002@mc.duke.edu
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Muir